These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31169696)

  • 1. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
    Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
    Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.
    Wang Y; Ren Z; Shen YH; Fang XG; Li QL; Zhong YS; Zhang YQ; Chen WF; Zhou PH; Lin SL
    Gastrointest Endosc; 2024 Sep; 100(3):481-491.e6. PubMed ID: 38431107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
    Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after endoscopic resection and the risk of lymph node metastasis in rectal neuroendocrine tumors: a single-center retrospective study.
    Tie SJ; Fan ML; Zhang JY; Yu J; Wu N; Su GQ; Xu Z; Huang WF
    Surg Endosc; 2024 Sep; 38(9):5178-5186. PubMed ID: 39043886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 10. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
    Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.
    Vanoli A; Albarello L; Uncini S; Fassan M; Grillo F; Di Sabatino A; Martino M; Pasquali C; Milanetto AC; Falconi M; Partelli S; Doglioni C; Schiavo-Lena M; Brambilla T; Pietrabissa A; Sessa F; Capella C; Rindi G; La Rosa S; Solcia E; Paulli M
    Am J Surg Pathol; 2019 Jun; 43(6):725-736. PubMed ID: 30913089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.
    Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
    Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).
    Chung CS; Tsai CL; Chu YY; Chen KC; Lin JC; Chen BC; Sun WC; Yen HH; Chen CY; Wu IC; Kuo CH; Shih HY; Bair MJ; Wang JP; Hu WH; Yang CS; Han ML; Cheng TY; Tseng CM; Tsai MC; Hu ML; Wang HP
    Medicine (Baltimore); 2018 Sep; 97(38):e12101. PubMed ID: 30235663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors.
    Blakely AM; Lafaro KJ; Li D; Kessler J; Chang S; Ituarte PHG; Lee B; Singh G
    Neuroendocrinology; 2020; 110(5):384-392. PubMed ID: 31401633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.
    Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH
    Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
    Hiyoshi Y; Daitoku N; Mukai T; Nagasaki T; Yamaguchi T; Akiyoshi T; Yasue C; Chino A; Saito S; Takamatsu M; Fukunaga Y
    Ann Surg Oncol; 2023 Jul; 30(7):3944-3953. PubMed ID: 36935432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
    Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
    Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.